Introduction
Among a large number of prototype structures explored to generate new drugs for helminth dis eases, the benzimidazoles have emerged as one of the most versatile classes of heterocycles which has undergone extensive molecular modification since the discovery of thiabendazole in 1960 [2, 3] . Ef forts to optimize the biological profile of benzimidazole has resulted in the discovery of a num ber of novel anthelmintics [4] such as mebendazole (27) , flubendazole (28) , fenbendazole (15) , ciclobendazole (26) , oxibendazole (9) and the recently introduced luxabendazole, all being the derivative of carbendazim (1) which is an established fungi cide rather than an anthelmintic.
A careful analysis of the disposition of various pharmacophores on different positions of benz imidazoles indicates that the anthelmintic profile of benzimidazole is governed by the nature of sub stituents present at its 2-and 5(6)-positions. More detail studies carried out in this direction have unequivocally established the need of a methoxyReprint requests to Dr. Shiv K. Agarwal.
Verlag der Zeitschrift für Naturforschung, D-72072 Tübingen 0939-5075/93/1100-0829 $01. 30/0 carbonylamino function at 2-position except for triclabendazole (VIII) which has methylthio func tion at 2-position. In addition, it has been ob served that the biological potency of the molecule can be modulated by introducing a proper phar macophore at 5-position. In majority of the cases the groups linked to the 5-position through a "spacer" like O, S, SO, S 0 2, CO, CH O H , CON H, N H C O etc. have a marked effect on the overall biological profile of the molecule. It appears that these spacers, play a major role in inducing biolog ical response against both tissue and intestinal hel minths. Accordingly, a large variety of 2,5-disubstituted benzimidazoles were prepared with or without a spacer at their 5(6)-position in this labo ratory. Evaluation of these compounds for their anthelmintic activity resulted in the development of a number of compounds, some being specific to intestinal roundworms and tapeworms like Ancylostoma ceylanicum, Syphacia obvelata, Hymenole pis nana etc., while other showed better activity against the tissue-dwelling helminths like Litom o soides carinii and Acanthocheilonema viteae. How ever, no attempt has been made to study the effect of above spacers in segregating the biological ac tivity against intestinal and tissue dwelling hel minths. The present paper attempts to rationalize the effect of spacers in segregating the activity pro- 
Materials and Methods

Synthesis
The synthesis of various methyl 5(6)-substituted benzimidazole-2-carbamates (Table I-V ) was achieved by cyclization of the corresponding o-phenylenediamines with 1,3-dicarbomethoxy-S-methylisothioureas according to literature pro cedures [2] .
Parasites and hosts
All the benzimidazoles were evaluated against Ancylostoma ceylanicum (hookworm) in hamsters, Syphacia obvelata (oxyurid) in mice, Hymenolepis nana (cestode) in rats, Litomosoides carinii in cotton rats and Acanthocheilonema viteae in Mastomys natalensis (coucha). Compounds being in soluble in water were made to fine suspensions with little amount of Tween 80 [5] . Two to three animals were used for each dose level and two to five replicates were done. The assessment of effica cy was done on autopsy under deep ether anaes thesia.
Ancylostoma ceylanicum ( Hookworm)
The drug testing was carried out using golden hamsters of either sex (50-60 g) infected orally with 50 ± 5 L3 (3rd stage larvae) of A. ceylanicum [6] . On day 17 post-inoculation, infection was checked by ovoscopic examination. Hamsters found positive were administered orally or intraperitoneally with compounds under test. The effi cacy was expressed in terms of absolute clearance of parasite from the host and percent worm reduc tion.
Syphacia obvelata ( Oxyurid)
The compounds were evaluated in either sex of Swiss albino mice (20-25 g ) carrying naturally ac quired infection of S'. obvelata. The criterion of ef ficacy was the absolute clearance of the parasites from the treated mice [5, 6] ,
Hymenolepis nana ( Cestode)
The efficacy assessment was made against egg (200) induced infection of H . nana in albino male rats (35-40 g ). The basis of drug efficacy was the complete elimination of worms along with scolices from the treated animals [7, 8] ,
Litomosoides carinii ( F ilaria l worm)
The micro-and macrofilaricidal activities of compounds were evaluated against L. carinii infec tion in cotton rats ( Sigmodon hispidus). The infec tion was transmitted to cotton rats through the vector Liponyssus bacoti by the method of Haw king and Sewell [9] . At the end of the prepatent pe riod, animals showing 250 or more microfilariae per 5 ml of blood were chosen for screening. Five animals formed an experimental group. Blood samples for experimental and control animals were examined before starting the treatment. All the compounds were given intraperitoneally (except compound 65 which was also administered orally) for 5 consecutive days. Blood smears of animals examined for microfilariae at weekly intervals up to 6 weeks from the start of the treatment. On day 42, all the treated and control animals were sacrified and the condition of adult male and female worms observed. The micro-and macro filaricidal action was assessed as described by Laemmler et al. [10] . For monitoring the macrofilaricidal ac tivity, blood samples of the rodents infected with L. carinii were examined at weekly intervals up to day 91.
Acanthocheilonema viteae ( F ilaria l worm)
The micro-and macrofilaricidal activities of the compounds were assessed against A. viteae in Mastomys natalensis as described for Litomosoides carinii. The infection was transmitted to Mastomys through the vector Ornithodoros mobata by the method of Worms et al. [11] .
Results
L A . ceylanicum
In general all the 5(6)-substituted benzimidazole-2-carbamates exhibited a wide-spectrum of activity against the hookworm, A. ceylanicum in hamsters. Incorporation of a pharmacophore with no spacer at 5(6)-position of the benzimidazole-2-carbamate (Table I) Table I . Anthelmintic profile of benzimidazole-2-carbamate (type II) with no "spacer" at 5 (6) (27) showing 100% clearance of the parasite at a dose of 1 mg/kg. Attempts to attach an electron donating group to the carbonyl group thereby reducing its electrophilic character retained the anthelmintic profile against A. cey lanicum. However, none of the compounds (31 -35) thus generated exceeded the potency of meben dazole (Table II) . Table II . Anthelmitic profile of benzimidazole-2-carbamates (type III) with one "spacer" at 5 (6) (Table III) . Enlargement of the inter-pharmacophoric dis tances by introducing two space (CONH or N H C O ) in benzimidazole-2-carbamates (Ta ble IV) had detrimental effect on the biological activity. The compounds with a CO N H spacer 
S. obvelata
The benzimidazole-2-carbamates having no spacer at 5(6)-position exhibited almost a similar pattern of activity against S. obvelata as reported for A. ceylanicum. Perbendazole (1) caused 90% of the clearance of the parasite at an oral dose of 10 -12 mg/kg, while 100% reduction of worm load achieved by compounds 2 and 4 at a higher dose of 250 mg/kg (Table I) .
Introduction of one spacer like O, S, SO or S 0 2 has been found to marginally improve the biologi- -- [31] 55 O c J cal profile of the compounds. All the compounds (9-24) of this class except 20 were found to be in active against S. obvelata at a single oral dose 250 mg/kg. Ricobendazole (20) (Table II) . Partial reduction of 27 into 36 increases the biological profile (100% clearance of worm at 50 mg/kg), while in the case of 37 a mark decrease in anthelmintic activity (100% ac tivity at 3 doses of 25 mg/kg) was observed.
Among the bisbenzimidazole-2-carbamates having one spacer flanked by two benzimidazole-2-carbamates, the optimal activity was achieved with compound (65) having carbonyl function, which showed 100% activity at a dose of 100 mg/ kg. When the dose was lowered to 50 mg/kg, it only eliminated 6 6 .6 % of the parasite. The meta bolite (67) of compound (65) exhibited a better spectrum of activity against this parasite. It elimi nated 8 8 .8 % and 100% of the worms at a dose of 50 mg/kg and 100 mg/kg respectively.
H . nana
The activity of various benzimidazole-2-carbamates, having different substitution pat tern at 5(6)-position is given in Table I -V . The compounds having no spacer showed poor activity against the dwarf tapeworm, H . nana in mice. Compounds (1, 5-7) were found to eliminate the 100% tapeworm at a dose of 250 mg/kg, while other compounds (2-4, 8 ) were found to be inac tive at this dose level (Table I) (Table II) . Conversion of 27 and 30 into the corresponding hydroxy com pounds 36 and 37, respectively, did not alter the biological profile significantly. The resulting com pounds showed almost equipotent activity against H. nana to their parent drug. Incorporation of the spacer in a cyclic form, which, in turn, forms the hetero atom of pyridine, indole or azaindole skeleton (33-43) led to com plete loss of activity against H . nana. However, formation of a quinazolone skeleton utilizing the spacer present at 5(6)-position of benzimidazole-2-carbamates (44-46) gave 100% response against H. nana a dose of 250 mg/kg (Table III) .
Among the benzimidazole-2-carbamates having two spacers at 5(6)-position, the presence of a car bonyl (CO) and N H was found to elicit wide spec trum of activity against H . nana. It was observed that compounds having CO N H spacer where CO is directly linked to benzimidazole-2-carbamate exhibited better activity than the benzimidazole-2-carbamate having CO N H, where N H group is directly linked to benzimidazole. The effective compounds of the former class were compounds (47,50, 53 and 54) of which optimal activity exhib ited by 54 at a dose of 3.12 mg/kg. The active com pound belonging to a latter class are 57-59 show ing 50-100% elimination of the tapeworm at a dose of 250 mg/kg (Table IV) .
In the bisbenzimidazole-2-carbamate, where the two heterocycles are separated by different spacers. The compounds (62-67) having spacers like O, S, S 0 2, CO, CH 2 and C H O H were found to kill the parasite 70-100% at a dose of 100-250 mg/kg. Substitution of any of these spacers with other spacers having more functionality (68-73) led to complete loss of activity, indicating to the fact that internuclear distance in such compounds may be essential for activity (Table V) .
L. carinii and A. viteae
It is difficult to draw the effect of the spacer at 5(6)-position of benzimidazole-2-carbamate on the antifilarial activity against L. carinii and A. viteae. However, available data show that compounds having one spacer are associated with marked an tifilarial activity for example, the oxygen congener (10) of mebendazole (27) showed 85% clearance of the adultworm in cotton rats infected with L. cari nii. Mebendazole (27) and flubendazole (28) Tables I-V , point out to the structure activity cor relate which may be summarized as follows.
The benzimidazole-2-carbamates having no spacer (Table I) , in general show poor or no activi ty against most of the helminths tested. This is probably due to the fact that compounds of type II though resist hydroxylation at 5-position to form inactive metabolites, do not exhibit a characteristic geometry of the pharmacophore thereby indicat ing to the fact that presence of a spacer is essential for anthelmintic activity. This observation may be best supported by compound 8 , which represents all the structural features of mebendazole except for the fact that a carbonyl spacer at 5(6)-position has been removed. The net result is that com pounds with no spacer have either poor or no ac tivity.
A further support to the above analysis may be received from the biological profile of the com pounds summarized in Table II . All the com pounds 9-37 have a pharmacophore linked to the 5-position of benzimidazole-2-carbamate through a spacer like O, S, S 0 2, CO and CH OH . Careful analysis of the anthelmintic activity of this class compounds would indicate that the activity broad ly follows the sequence O < S < S O < C O . This is probably due to the fact the benzimidazole-2-carbamates with oxygen spacer are resistant to various metabolic reactions at 5(6)-position, there by are less bioavailable. Contrary to this the benzimidazole-2-carbamates having a sulphur spacer at 5(6)-position may under go successive cytochrome P450 dependent oxidations in the biophase to form sulphoxide and sulphone. Consequently compounds of this class are expected to attain higher peak plasma concentration with better an thelmintic activity. This may be further supported by the high anthelmintic activity exhibited by al bendazole (14) , fenbendazole (15) , oxfendazole (20) , of which 20 is the active metabolite of 15. The development of two injectable sulphoxide anthel mintics by squibb laboratories may be taken as ad ditional support to the above hypothesis. Thus compounds having carbonyl spacers exhibit maxi mal anthelmintic activity. The most effective mem ber of this class are ciclobendazole (26) , mebenda zole (27) , flubendazole (28) nocodazole (30) and C D R I 81-470 (35) . All these compounds are highly prone to oxido-redox enzyme systems, leading to the formation of corresponding carbinols as one of the major metabolites. These carbinols may show additive or synergistic action with other metabo lites arising due to metabolic reaction at 2-position.
The resultant effect is better bioavailability and higher activity against both intestinal and tissue helminths. Recently McCracken and Lipkowitz [12] have analyzed various pharmacophoric re quirement in benzimidazole-2 -carbamate having one spacer at 5(6)-position and have concluded by molecular modelling that the 5-substituents twist ed out of plane were more active than those anthel mintics with 5-substituents in plane.
Incorporation of one spacer in cyclic forms lead ing to the formation of heterocycles like 38-46 generally gives rise to poor activity (Table III) . This indicates to the fact that the groups attached to 5-position through a spacer should have free ro tation in order to attain a preferred L-shaped cleft confirmation while approaching to the receptor site.
The benzimidazole-2-carbamates having groups at 5-position linked by two spacers like CO N H (47-54) and N H C O (55-60) also exhibit moder ate to poor activity. Compounds of this class though prone to various metabolic degradations and also free rotation across C-C bond and C-N bond do not exhibit activity comparable to the corresponding benzimidazoles having one spacer. This points out to the fact that in addition to the groups susceptible to enzymatic reaction and free rotation of the groups attached to such spacers, the distance between benzimidazole nucleus and the pharmacophore attach to 5(6)-position is also determinantal in evoking biological activity.
Foregoing discussion would indicate that the presence of one spacer at 5(6)-position of benzimidazole-2-carbamate plays a major role in eliciting an thelmintic response. This may be supported by the analysis of the biological activity exhibited by the bisbenzimidazole-2-carbamate (62-73, Table V) .
As observed in compounds with one spacer (Table II) , the profile of activity in bisbenzimidazole attach to one spacer like O, S, S 0 2, CO, C H 2 and CH O H was complimentary O < S < S 0 2 < CO.
The results summarized in Table V. The weak anthelmintic activity exhibited by bisbenzimidazole-2-carbamates (68-73) would further indi cate that the interpharmacophoric distances linked to at 5(6)-position of the benzimidazole-2-carbamate is also detrimental in giving rise to high anthelmintic activity.
The above discussion points out that the mini mal structural requirement of the substituent present at 5(6)-position of benzimidazole-2-carbamate for the optimal anthelmintic activity are (i) the presence of only one spacer like O, S and CO which are prone to various metabolic reactions in biophase resulting in either bioavailability or con version of the drug into an active metabolite hav ing either synergistic or additive action with the parent molecule (ii) the pharmacophore attached with the above spacers must have a free rotation across its various single bonds which probably helps in attaining a preferred L-shaped orientation while approaching to the receptor site (iii) the dis tance between the benzimidazole nucleus and the pharmacophore linked at 5(6)-position through one spacer is also detrimental. Usually, 3 Ä + of the spacer Van der Waals-radii. Simulation of these structural requirement is expected to lead compounds with activity against the intestinal hel minths. For obtaining compounds having activity against the tissue dwelling parasites the com pounds must have a spacer like C H O H or SO which imparts better water solubility or repetition of the benzimidazole-2-carbamate nucleus linked through only one spacer.
